359,000 clinicians participating in 4 APMs in 2017

CMS has announced which clinicians and accountable care organizations are participating in four alternative payment models (APMs) in 2017: the Medicare Shared Savings Program (MSSP) Next Generation ACO Model, the Comprehensive End-Stage Renal Disease Care Model (CEC) and Comprehensive Primary Care Plus (CPC+) Model.

The final tally has more than 359,000 participating clinicians, serving than 12.3 beneficiaries in Medicaid and Medicare.

“By listening to physicians and engaging them as partners, CMS has been able to develop innovative payment reforms that bring physicians back to the core practice of medicine – caring for the patient,” CMS Acting Administrator Andy Slavitt said in a statement. “By reducing regulatory burden and paying for quality, CMS is offering solutions that improve the quality of services our beneficiaries receive and reduce costs, to help ensure the Medicare program is sustainable for generations to come.”

572 ACOs are participating in CEC, Next Generation ACO, or MSSP. 131 of them are in a risk-bearing track within those programs.

Here’s how the number of new and returning participants break down:

  • MSSP: 99 new, 79 returning
  • Next Gen ACO: 28 new, 17 returning
  • CEC: 24 new, 23 returning

For primary care, 2,893 practices are participating in CPC+.

Next Generation ACO and CPC+ participants, as well MSSP ACOs on Tracks 2 and 3, will be eligible for the 5 percent APM bonus in 2017 thanks to the Medicare Access and CHIP Reauthorization Act. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup